Altering behavior with gene transfer in the limbic system

Physiology and Behavior

Volumn 79, Issue 3, 2003, Pages 479-486

  Sapolsky, Robert M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Behavior; Gene transfer; Limbic system

Indexed keywords

11B HYDROXYSTEROID DEHYDROGENASE 2; ADENOVIRUS VECTOR; ANTIOXIDANT; ARGIPRESSIN RECEPTOR; ARGIPRESSIN RECEPTOR BLOCKING AGENT; CALCIUM BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID ANTAGONIST; GLUCOSE TRANSPORTER; GLUTAMATE RECEPTOR; HEAT SHOCK PROTEIN; KIDNEY ENZYME; NERVE GROWTH FACTOR; NEUROTROPHIN; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADDICTION; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL; ANIMAL BEHAVIOR; BEHAVIOR; BEHAVIOR GENETICS; CELL TRANSPLANTATION; COCAINE DEPENDENCE; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DNA MODIFICATION; DRUG HALF LIFE; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETICS; HERPES SIMPLEX VIRUS 1; HIPPOCAMPUS; HORMONE RELEASE; HUMAN; LIMBIC SYSTEM; LONG TERM POTENTIATION; MEMORY DISORDER; MENTAL STRESS; NERVE CELL PLASTICITY; NERVOUS SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REPORTER GENE; SOCIAL BEHAVIOR; STEM CELL; STEROID RELEASE; STRESS; SUBSTANCE ABUSE; VENTRAL TEGMENTUM; VIRAL GENE DELIVERY SYSTEM;

EID: 0041381409     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(03)00153-7     Document Type: Conference Paper

References (44)

1. Nakazawa K., Quirk M., Chitwood R., Watanabe M., Yeckel M., Sun L.et al. Requirement for hippocampal CA3 NMDA receptors in associative memory recall. Science. 297:2002;211-218.
2. Carlezon W., Nestler E., Neve R. HSV-mediated gene transfer as a tool for neuropsychiatric research. Crit. Rev. Neurobiol. 14:2000;47-59.
3. Fink D., DeLuca N., Yamada M., Wolfe D., Glorioso J. Design and application of HSV vectors for neuroprotection. Gene Ther. 7:2000;115-121.
4. Ho D.Y., Sapolsky R. Gene therapy in the nervous system. Sci. Am. 1997 (July);116-123.
5. Hsich G., Sena-Esteves M., Breakefield X. Critical issues in gene therapy for neurologic disease. Hum. Gene Ther. 13:2002;579-604.
6. Cao Y., Shibata T., Rainov N. Liposome-mediated transfer of the bcl-2 gene results in neuroprotection after in vivo transient focal cerebral ischemia in an animal model. Gene Ther. 9:2002;415-419.
7. Ozawa C., Ho J., Tsai D., Ho D., Sapolsky R. Neuroprotective potential of a stress-induced viral vector system. Proc. Natl. Acad. Sci. U. S. A. 97:2000;9270-9275.
8. Sapolsky R. Neuroprotective gene therapy. Nat. Rev., Neurosci. 4:2003;61-66.
9. Constantini L., Jacoby D., Wang S., Fraefel C., Breakefield X., Isacson O. Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/AAV amplicon vectors. Hum. Gene Ther. 10:1999;2481-2487.
10. Bowers W., Howard D., Federoff H. Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease. Exp. Neurol. 144:1997;58-67.
11. Zyzak D., Otto T., Eichenbaum H., Gallagher M. Cognitive decline associated with normal aging in rats: a neuropsychological approach. Learn. Mem. 2:1995;1-16.
12. Bartus R. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol. 163:2000;495-529.
13. Backman C., Rose G., Hoffer B., Henry M., Bartus R., Friden P.et al. Systemic administration of NGF conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy. J. Neurosci. 16:1996;5437-5442.
14. Fischer W., Wictorin K., Bjorklund A., Williams L., Varon S., Gage F. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by NGF. Nature. 329:1987;65-68.
15. Knusel B., Kaplan D., Hefti F. Intraparenchymal NGF injections in adult and aged rats induce long-lasting Trk tyrosine phosphorylation. Exp. Neurol. 138:1996;121-130.
16. Martinez-Serrano A., Bjorklund A. Ex vivo NGF gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging. Proc. Natl. Acad. Sci. U. S. A. 95:1998;1858-1863.
17. Chen K., Gage F. Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration. J. Neurosci. 15:1995;2819-2825.
18. Kelley A., Berridge K. The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 22:2002;3306-3311.
19. Terwilliger R., Beitner-Johnson D., Severino K., Crain S., Nestler E. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:1991;100-110.
20. Cole R., Konradi C., Douglass J., Human S. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron. 14:1995;813-823 Unterwald E., Fillmore J., Kreek M. Chronic repeated cocaine administration increases dopamine D1 receptor-mediated signal transduction. Eur. J. Pharmacol. 318:1996;31-35.
21. Cole R., Konradi C., Douglass J., Human S. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron. 14:1995;813-823 Unterwald E., Fillmore J., Kreek M. Chronic repeated cocaine administration increases dopamine D1 receptor-mediated signal transduction. Eur. J. Pharmacol. 318:1996;31-35.
22. Bals-Kubik R., Albleitner A., Herz A., Shippenberg T. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264:1993;489-495.
23. Carlezon W., Thome J., Olson V., Lane-Ladd S., Brodkin E., Hiroi N.et al. Regulation of cocaine reward by CREB. Science. 282:1998;2272-2275.
24. Nestler E. Total recall - the memory of addiction. Science. 292:2001;2266-2267.
25. Ungless M., Whistler J., Malenka R., Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature. 411:2001;583-587.
26. Carlezon W., Boundy V., Haile C., Lane S., Kalb R., Neve R.et al. Sensitization to morphine induced by viral-mediated gene transfer. Science. 277:1997;812-814.
27. Wilson E.O. Sociobiology. 1975;Harvard Univ. Press, Campbridge, MA, USA.
28. Insel T., Young L. The neurobiology of attachment. Nat. Rev., Neursoci. 2:2001;129-135.
29. Winslow J., Hastings N., Carter C., Harbaugh C., Insel T. A role for central vasopressin in pair bonding in monogamous prairie voles. Nature. 365:1993;545-548.
30. Cho M., DeVries C., Williams J., Carter C. The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behav. Neurosci. 113:1999;1071-1079.
31. Insel T., Wang Z., Ferris C. Patterns of brain vasopressin receptor distribution associated with social organization in microtine rodents. J. Neurosci. 14:1994;5381-5392.
32. Pitkow L., Sharer C., Ren X., Insel T., Terwilliger E., Young L. Facilitation of affiliation and pair-bond formation by vasopressin receptor gene transfer into the ventral forebrain of a monogamous vole. J. Neurosci. 21:2001;7392-7396.
33. Kim J., Diamond D. The stressed hippocampus, synaptic plasticity and lost memories. Nat. Rev., Neurosci. 3:2002;453-461.
34. LeDoux J. Emotion circuits in the brain. Annu. Rev. Neurosci. 23:2000;155-184.
35. Vyas A., Mitra R., Rao B., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 22:2002;6810-6816 McEwen B. Effects of adverse experiences for brain structure and function. Biol. Psychiatry. 48:2000;721-731.
36. Vyas A., Mitra R., Rao B., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 22:2002;6810-6816 McEwen B. Effects of adverse experiences for brain structure and function. Biol. Psychiatry. 48:2000;721-731.
37. Sapolsky R. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry. 57:2000;925-935.
38. Nottebohm F. Why are some neurons replaced in adult brain? J. Neurosci. 22:2002;624-628.
39. Gould E., Tanapat P. Stress and hippocampal neurogenesis. Biol. Psychiatry. 46:1999;1472-1479.
40. Diamond D., Bennet M., Fleshner M., Rose G. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus. 2:1992;421-430.
41. Kang W., Wilson S., Wilson M. Overexpression of proenkephalin in the amygdala potentiates the anxiolytic effects of BDZs. Neuropsychopharmacology. 22:2000;77-85.
42. Landgraf R., Gerstberger R., Montkowski A., Probst J., Wotjak C., Holboer G.et al. V1 vasopressin receptor antisense oligonucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J. Neurosci. 15:1995;4250-4258.
43. Sapolsky R., Romero M., Munck A. How do glucocorticoids influence the stress-response? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21:2000;55-81.
44. Marshal E. Major setback in French gene therapy trial. Science. 298:2002;510-511.